The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Mravyan S.R.

V.I. Krasnopolsky Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Britvin T.A.

M.F. Vladimirsky Moscow Regional Clinical Research Institute

Kovalenko T.S.

V.I. Krasnopolsky Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Stepanova E.A.

M.F. Vladimirsky Moscow Regional Clinical Research Institute

Budykina T.S.

V.I. Krasnopolsky Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Aksenov A.N.

V.I. Krasnopolsky Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Clinical case of primary hyperaldosteronism detected during pregnancy: differential diagnosis, neonatal prognosis

Authors:

Mravyan S.R., Britvin T.A., Kovalenko T.S., Stepanova E.A., Budykina T.S., Aksenov A.N.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2025;25(2): 98‑104

DOI: 10.17116/rosakush20252502198

Read: 438 times

Buy for 300₽
Contact the author
Table of contents

CLINICAL CASE OF PRIMARY HYPERALDOSTERONISM DETECTED DURING PREGNANCY: DIFFERENTIAL DIAGNOSIS, NEONATAL PROGNOSIS
CLINICAL CASE OF PRIMARY HYPERALDOSTERONISM DETECTED DURING PREGNANCY: DIFFERENTIAL DIAGNOSIS, NEONATAL PROGNOSIS

To cite this article:

Mravyan SR, Britvin TA, Kovalenko TS, Stepanova EA, Budykina TS, Aksenov AN. Clinical case of primary hyperaldosteronism detected during pregnancy: differential diagnosis, neonatal prognosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;25(2):98‑104. (In Russ.)
https://doi.org/10.17116/rosakush20252502198

 
Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Pecu­liarities of placental microRNA expression in patients with preeclampsia and fetal growth restriction. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):14-25
Changes in the type of psychological component of the gestational domi­nant in pregnant women in the third trimester after completing the peri­natal preparation program. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):66-71
Sexual function of women during pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):112-117
Local cyto­kine profile of the endo­metrium in patients with repeated implantation failures and its pharmacological correction by the secretome of peri­pheral blood mono­nuclear cells. Russian Journal of Human Reproduction. 2024;(5):46-54
Immu­nological aspe­cts of reccurent pregnancy loss. Russian Journal of Human Reproduction. 2024;(5):64-71
Difficulties in life­time diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27
Dyna­mics of Substance P and Fila­ggrin Levels on Combined Treatment of Atopic Dermatitis with Emollient and Topi­cal Anti­pruritic Drug in Pregnant Women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):662-666
Clinical case of auri­cular gouty tophi. Russian Bulletin of Otorhinolaryngology. 2024;(6):80-84
Functional cyto­kine redu­ndancy in pregnancy. Russian Journal of Human Reproduction. 2024;(6):73-80
Clinical case of successful pregnancy in a patient with ecto­pic ACTH syndrome after radi­cal surgical treatment. Russian Journal of Human Reproduction. 2024;(6):118-123
Abstract:

Based on the clinical observation of primary hyperaldosteronism (PHA) diagnosed during pregnancy, an analysis of the course of this disease and the features of hormonal regulation are presented. Special attention is paid to the clinical picture of PHA in pregnant women, often represented by minor and variable hypokalemia, borderline arterial hypertension, as well as the differential diagnosis of the disease. Primarily it was suggested that rebound hyperkalemia develops in a newborn, the mechanism of which remains unclear, which places increased demands on the neonatal service.

Keywords:

pregnancy
primary hyperaldosteronism
diagnostics
newborn prognosis

Authors:

Mravyan S.R.

V.I. Krasnopolsky Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Britvin T.A.

M.F. Vladimirsky Moscow Regional Clinical Research Institute

Kovalenko T.S.

V.I. Krasnopolsky Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Stepanova E.A.

M.F. Vladimirsky Moscow Regional Clinical Research Institute

Budykina T.S.

V.I. Krasnopolsky Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Aksenov A.N.

V.I. Krasnopolsky Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Received:

31.01.2024

Accepted:

21.02.2024

Close metadata

References:

  1. Kopytina PA. Arterial hypertension during pregnancy. Alleya nauki. 2020;1:94-105. (In Russ.).
  2. Agrawal A, Wenger NK. Hypertension during pregnancy. Curr Hypertens Rep. 2020;22:1-9. 
  3. Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012;206:134.e1-8. 
  4. Forestiero V, Sconfienza E, Mulatero P, Monticone S. Primary aldosteronism in pregnancy. Rev Endocr Metab Disord. 2023;24:39-48.  https://doi.org/10.1007/s11154-022-09729-6
  5. Solov’iev EV, Popova NA, Vlasova T, Gorbunova ML, Shestakova AV. Diagnostic errors and difficulties in managing patients with primary hyperaldosteronism. Meditsinskii al’manakh. 2020;3:64:91-95. (In Russ.).
  6. Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro M-C, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin Y-H, Fallo F, Widimsky J. Genetics, prevalence, screening and confirmation of primary aldosteronism: A position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens. 2020;38:10:1919-1928. https://doi.org/10.1097/HJH.0000000000002510
  7. Shifman BM, Platonova NM, Molashenko NV, Troshina EA, Sitkin II, Bel’tsevich DG, Kovalevich LD, Romanova NYu, Kolesnikova GS. Primary hyperaldosteronism: diagnostic difficulties (clinical case and brief review). Terapevticheskii arkhiv. 2019;91:91-99. (In Russ.). https://doi.org/10.26442/00403660.2019.10.000138
  8. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello M-J, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F; PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:11:2293-2300. https://doi.org/10.1016/j.jacc.2006.07.059
  9. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40:892-896.  https://doi.org/10.1161/01.hyp.0000040261.30455.b6
  10. Quartermaine G, Lambert K, Rees K, Seed PT, Dhanjal MK, Knight M, McCance DR, Williamson C. Hormone-secreting adrenal tumours cause severe hypertension and high rates of poor pregnancy outcome: a UK Obstetric Surveillance System study with case control comparisons. BJOG. 2018;125:719-727.  https://doi.org/10.1111/1471-0528.14918
  11. Crane MG, Andes JP, Harris JJ, Slate WG. Primary aldosteronism in pregnancy. Obstet Gynecol. 1964;23:200-208. 
  12. Wilson M, Morganti AA, Zervoudakis I, Letcher RL, Romney BM, Von Oeyon P, Papera S, Sealey JE, Laragh JH. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med. 1980;68:97-104.  https://doi.org/10.1111/j.1365-2265.2010.03901.x
  13. Morton A. Primary aldosteronism and pregnancy. Pregnancy Hypertens. 2015;5:259-262.  https://doi.org/10.1016/j.preghy.2015.08.003
  14. Ronconi V, Turchi F, Zennaro MC, Boscaro M, Giacchetti G. Progesterone increase counteracts aldosterone action in a pregnant woman with primary aldosteronism. Clin Endocrinol (Oxf). 2011;74:278-279.  https://doi.org/10.1111/j.1365-2265.2010.03901.x
  15. Lewandowski KC, Tadros-Zins M, Horzelski W, Krekora M, Lewinski A. Renin, Aldosterone, and Cortisol in Pregnancy-Induced Hypertension. Exp Clin Endocrinol Diabetes. 2023;131:222-227.  https://doi.org/10.1055/a-2025-0510
  16. Gant NF, Worley RJ, Everett RB, MacDonald PC. Control of vascular responsiveness during human pregnancy. Kidney Int. 1980;18:253-258.  https://doi.org/10.1038/ki.1980.133
  17. Eguchi K, Hoshide S, Nagashima S, Maekawa T, Sasano H, Kario K. An adverse pregnancy-associated outcome due to overlooked primary aldosteronism. Intern Med. 2014;53:2499-2504. https://doi.org/10.2169/internalmedicine.53.2762
  18. Okawa T, Asano K, Hashimoto T, Fujimori K, Yanagida K, Sato A. Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature. Am J Perinatol. 2002;19:31-36.  https://doi.org/10.1055/s-2002-20170
  19. Morton A. Physiological Changes and Cardiovascular Investigations in Pregnancy. Heart Lung Circ. 2021;30:e6-e15.  https://doi.org/10.1016/j.hlc.2020.10.001
  20. Sanga V, Seccia TM, Rossi GP. A systematic review of pathophysiology and management of familial hyperaldosteronism type 1 in pregnancy. Endocrine. 2021;74:5-10.  https://doi.org/10.1007/s12020-021-02763-5
  21. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science. 2000;289:119-123.  https://doi.org/10.1126/science.289.5476.119
  22. Pintavorn P, Munie S. A Case Report of Recurrent Hypokalemia During Pregnancies Associated With Nonaldosterone-Mediated Renal Potassium Loss. Can J Kidney Health Dis. 2021:8: 20543581211017424. https://doi.org/10.1177/20543581211017424
  23. Landau E, Amar L. Primary aldosteronism and pregnancy. Ann Endocrinol (Paris). 2016;77:148-160.  https://doi.org/10.1016/j.ando.2016.04.009
  24. Aoi W, Doi Y, Tasaki S, Mitsuoka T, Suzuki S, Hashiba K. Primary aldosteronism aggravated during peripartum period. Jpn Heart J. 1978;19:946-953.  https://doi.org/10.1536/ihj.19.946
  25. Murakami T, Ogura EW, Tanaka Y, M. Yamamoto. High blood pressure lowered by pregnancy. Lancet. 2000;356:9246:1980. https://doi.org/10.1016/s0140-6736(00)03311-0
  26. Nezu M, Miura Y, Noshiro T, Inoue M. Primary aldosteronism as a cause of severe postpartum hypertension in two women. Am J Obstet Gynecol. 2000;182:745-746.  https://doi.org/10.1067/mob.2000.104229
  27. Kilmartin C, Opu T, Podymow T, Dayan N. Primary hyperaldosteronism presenting as persistent postpartum hypertension: Illustrative case and systematic review. Obstet Med. 2019;12:190-195.  https://doi.org/10.1177/1753495X18772999
  28. Williams TA, Dietz AS, Theodoropoulou M, Riester A, Fischer E, Burrello J, Treitl M, Geyer L, Veglio F, Bidlingmaier M, Schopohl J, Beuschlein F, Mulatero P, Reincke M. Coexisting prolactinoma and primary aldosteronism: Is there a pathophysiological link? J Clin Endocrinol Metab. 2015;100:9:E1262—E1269. https://doi.org/10.1210/JC.2015-2422
  29. Zelinka T, Petrak O, Rosa J, Holaj R, Štrauch B, Widimský JJr. Primary aldosteronism and pregnancy. Kidney Blood Press Res. 2020;45:275-285.  https://doi.org/10.1159/000506287
  30. Mascetti L, Bettinelli A, Simonetti GD, Tagliabue A, Syrén ML, Nordio F, Bianchetti MG. Pregnancy in inherited hypokalemic salt-losing renal tubular disorder. Obstet Gynecol. 2011;117:512-516.  https://doi.org/10.1097/AOG.0b013e3182075317
  31. Osumi K, Suga K, Suzue M, Nakagawa R, Kagami S. Neonatal rebound hyperkalemia associated with ritodrine alone: a case report. BMC Pediatr. 2021;21:370.  https://doi.org/10.1186/s12887-021-02840-8
  32. Japan Council for Quality Health Care. Japan Obstetrics Compensation System for Cerebral Palsy: Report for Preventive Measure. [in Japanese]. (ed. Japan Council for Quality Health Ca.  https://www.sanka-hp.jcqhc.or.jp/documents/english/pdf/looking_back_over10years_after_system_was_launched201906.pdf.
  33. Tanaka K, Mori H, Sakamoto R, Matsumoto S, Mitsubuchi H, Nakamura K, Iwai M. Early-onset neonatal hyperkalemia associated with maternal hypermagnesemia: a case report. BMC Pediatr. 2018;18:55.  https://doi.org/10.1186/s12887-018-1048-4
  34. Riester A, Reincke M. Progress in primary aldosteronism: mineralcorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Eur J Endocrinol. 2015;172:1:R23-30. 
  35. Affinati AH, Auchus RJ. Endocrine causes of hypertension in pregnancy. Gland Surg. 2020;9:69-79. 
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.